Transforming the Healthcare Ecosystem with AI Technology
Leading Internet healthcare solutions provider Fangzhou Inc. (06086.HK) celebrated the successful integration and local implementation of the DeepSeek-R1 open-source large language model [on February 8, 2025]. More accurate and individualized healthcare solutions for patients and healthcare providers will be made possible by this upgrade, which is anticipated to increase the company’s service capabilities and operational efficiency as well as enhance the Internet healthcare industry as a whole.
As of June 30, 2024, Fangzhou Inc.(06086.HK) was the top online chronic disease management platform in China, with 217,000 physicians and 45.6 million registered users. For individuals with chronic illnesses, the company offers precision medicine solutions and individualized medical treatment.
Using AI to Transform the Healthcare Ecosystem
Fangzhou Inc. can provide data-driven decision assistance and additional functionality while keeping complete control over privacy and data protection because of the local deployment of DeepSeek-R1’s sophisticated analytical and reasoning capabilities. The platform can better meet the needs of a wide range of patients and healthcare professionals by utilising DeepSeek’s technical advantages.
For patients there are benefits. By offering analysis of test results, medical reports, and other health data, the platform improves health management. By using these information, medical professionals can provide post-diagnosis care plans and pharmaceutical advice.
For Healthcare Providers there are also benefits. By streamlining prescription reviews and patient administration, Fangzhou’s DeepSeek-R1 powered “AI Assistant” frees up physicians to concentrate on other important medical duties. Science-based decision support is also incorporated into the data-driven logic of the model, which helps with diagnostic and treatment plan optimization.
Dr. Xie Fangmin, Founder, Chairman, and CEO of Fangzhou, commented, “The integration of DeepSeek marks an important step in our commitment to technological innovation. We believe this upgrade can bring significant improvements to our platform’s capabilities, allowing us to deliver better, more efficient healthcare services. We look forward to continuing to develop innovative solutions to our millions of users.”
Developing New Ideas for the Future
In order to use DeepSeek-R1’s potent analytical reasoning capabilities and get a deeper understanding of medical data, Fangzhou Inc.is concentrating on creating several “AI Agent” applications this year, Fangzhou hopes to improve the efficiency and accuracy of Internet healthcare by developing customized “AI Agent” solutions.
About Deepseek
A Chinese artificial intelligence business that specializes in creating large language models (LLMs). The company – Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd., commonly referred to as “DeepSeek” in the marketplace. It is owned and financed by the Chinese hedge fund High-Flyer and is headquartered in Hangzhou, Zhejiang. High-Flyer founded DeepSeek in July 2023, and in January 2025, the business released its DeepSeek-R1 model and an eponymous chatbot.